Mutant HSPB8 causes motor neuron-specific neurite degeneration

Joy Irobi1, Leonardo Almeida-Souza, Bob Asselbergh

  • 1Peripheral Neuropathy, VIB Department of Molecular Genetics, University of Antwerp, Antwerp, Belgium.

Insights

Missense mutations in HSPB8 cause motor neuron disease by damaging neurites without cell death. Only motor neurons are affected, explaining the specific disease phenotype in distal HMN and CMT2L.

Area of Science:

  • Neuroscience
  • Genetics
  • Cell Biology

Background:

  • Missense mutations in the small heat shock protein HSPB8 (HSP22) alpha-crystallin domain lead to distal hereditary motor neuropathy (distal HMN) and Charcot-Marie-Tooth neuropathy type 2L (CMT2L).
  • The precise mechanism by which mutant HSPB8 causes these specific motor neuron diseases remains unclear.

Purpose of the Study:

  • To investigate the cellular mechanisms underlying mutant HSPB8-induced neurodegeneration.
  • To determine the cell-type specificity of HSPB8 mutations' effects.

Main Methods:

  • Primary neuronal and glial cell cultures were utilized to compare the effects of mutant HSPB8 expression.
  • Expression of HSPB8 K141N and K141E mutations was analyzed in motor neurons, sensory neurons, cortical neurons, and glial cells.

Main Results:

  • Expression of mutant HSPB8 (K141N and K141E) induced significant neurite degeneration in motor neurons, characterized by reduced neurite number and length.
  • The K141E mutation, and to a lesser extent K141N, caused spheroid formation in motor neuron neurites.
  • Neurite degeneration occurred without inducing apoptosis in motor neurons.
  • Phenotypic alterations were minimal in sensory neurons and absent in cortical neurons and glial cells.

Conclusions:

  • Mutant HSPB8 specifically affects motor neurons, leading to neurite degeneration without cell death.
  • This cell-type specificity explains the predominant motor neuron involvement observed in distal HMN and CMT2L.
  • HSPB8 mutations represent a targeted mechanism for motor neuron dysfunction in specific neuropathies.